Last reviewed · How we verify
NCT06264622: GARDOSE
ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension
NA trial testing Low dose in Hypertension in 180 participants. Status unknown.
31 October 2024
Quick facts
| Lead sponsor | Universitat de Lleida |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 180 |
| Start date | 26 February 2024 |
| Primary completion | 31 October 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Low dose
- High dose
- Placebo
Conditions studied
- Hypertension — all drugs for Hypertension →
Sponsor
Universitat de Lleida
Who can join
Adults 18 to 75, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this clinical trial is to evaluate the dose response effect on cardiovascular disease risk factors of a Black Garlic Extract in subjects with Grade I Hypertension. The main questions it aims to answer are: * If the reduction in blood pressure (systolic and diastolic) is in a dose-response manner * If the changes in lipid profile are in a dose-response manner Participants will be randomly assign to a low dose (250 mg/day), high dose (600 mg/day) or placebo of a standardized Garlic Extract (ABG+/GarlACE) during 12 weeks
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06264622
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Low dose
Trials testing the same drug.
- NCT06214338 — Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β) · NA · completed
- NCT05158413 — High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety · NA · unknown
- NCT05178667 — Food Supplement Effect on Overweight or Moderate Obesity · NA · completed
- NCT04439695 — Study to Evaluate the Safety and Immunogenicity of KBP-V001 Quadrivalent Influenza Vaccine in Healthy Adults · Phase 1 · completed
- NCT04074616 — Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation · NA · completed
Other recruiting trials for Hypertension
Currently open trials in the same condition.
- NCT07413159 — The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans A · NA · recruiting
- NCT07361276 — Observational Study That Will Evaluate Treatment Patterns in the Management of Hypertension in the Public Primary Care S · recruiting
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07238400 — Cardiac Effects of Mineralocorticoid Receptor Antagonism After Preeclampsia · Phase 2 · recruiting
- NCT07135505 — Early Time-Restricted Eating in Older Adults With Hypertension · NA · recruiting
Other Universitat de Lleida trials
Trials by the same sponsor.
- NCT06809894 — Management of Non-pharmacologic Delirium With the Use of a Nursing-led E-health Project: a Randonmized Controlled Trial · NA · not yet recruiting
- NCT07381881 — GEL-AID: Safe and Effective Hydration for Institutionalized Older Adults · NA · not yet recruiting
- NCT07200505 — Telerehabilitation for Core Stability and Strength in Hereditary Ataxia · NA · not yet recruiting
- NCT06912373 — Experiences, Outcomes and Unmet Needs of Caregivers of Children With Cerebral Palsy · not yet recruiting
- NCT06621355 — HemoNIRS: a Paradigm Shift in the Process of Musculoskeletal Rehabilitation of ACL Injuries in Cyclic Sports Athletes. · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06264622 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universitat de Lleida
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06264622.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing